fridays health glp 1 Health: GLP-1 Weight Clinic Case Study Fridays Health Review: GLP-1, Nutrition,

Secondary endpoints at the 12mg dose included: fasting insulin reduction of 41%, triglyceride reduction of ~40%, waist circumference reduction of 18.5 cm, and meaningful improvements in liver fat fraction on MRI in a subset of participants

These changes confirm the medication is working at a metabolic level, not just suppressing appetite

Recent discoveries shed additional light on the potential role of FAO within specific CD8+ TME subsets

GLP-1 agonists primarily cause gastrointestinal side effects

Johns Wort interacts with the chemotherapy drugs irinotecan 20 , imatinib 21 and docetaxel 22 by reducing the amount of medication circulating in the blood

[6] KPV KPV in Gut Inflammation Control The study concluded that KPV reduces inflammation by getting into cells through the PepT1 transporter, where it slows down overactive immune and intestinal cell signals (NF-B and MAPK), which lowers the production of molecules that cause inflammation